T. Rowe Price Associates’s Allergan plc AGN.PRA Stock Holding History

T. Rowe Price Associates’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-42,876	Closed	-$25.1M	–	2624
2017 Q4	$25.1M	Sell	42,876 -31,128	-42%	-$20.1M	﹤0.01%	1108
2017 Q3	$53.9M	Buy	74,004 +740	+1%	+$614K	0.01%	820
2017 Q2	$63.2M	Sell	73,264 -14,951	-17%	-$12.5M	0.01%	749
2017 Q1	$74.4M	Sell	88,215 -573	-0.6%	-$475K	0.01%	680
2016 Q4	$66.5M	Hold	88,788	–	–	0.01%	718
2016 Q3	$72.5M	Sell	88,788 -848	-0.9%	-$733K	0.01%	677
2016 Q2	$74M	Sell	89,636 -148,820	-62%	-$124M	0.02%	658
2016 Q1	$220M	Sell	238,456 -141,514	-37%	-$135M	0.05%	377
2015 Q4	$388M	Sell	379,970 -172,900	-31%	-$174M	0.08%	255
2015 Q3	$513M	Buy	552,870 +4,045	+0.7%	+$4.22M	0.11%	202
2015 Q2	$570M	Buy	+548,825	New	+$575M	0.12%	198

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

T. Rowe Price Associates's AGN.PRA Position: Q1 2018 in Review

T. Rowe Price Associates sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 42,876 shares — an estimated $25.1M sold.

T. Rowe Price Associates first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $570M in Q2 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

T. Rowe Price Associates reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
T. Rowe Price Associates sold 42,876 Allergan plc shares in Q1 2018, an estimated $25.1M.
T. Rowe Price Associates first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
T. Rowe Price Associates's Allergan plc position peaked at $570M in Q2 2015.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.